Omnicell

SEPTEMBER 5, 2022

Scott Seidelmann EVP and Chief Commercial Officer, Omnicell As COVID-19 continues to impact healthcare across the care continuum, the need for solutions designed to help providers achieve greater visibility, control costs, and better manage an increasingly complex pharmacy supply chain is more important than ever.

Omnicell 52

Omnicell Documentation Patient Care 52

Omnicell

SEPTEMBER 5, 2022

Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion.

Omnicell 52

Omnicell Controlled Substances Hospitals Documentation 52

Omnicell

SEPTEMBER 5, 2022

Juliana Linsdell Nurse Consultant, Omnicell Nursing is a healthcare profession that represents the cross section of art and science, heart and mind, and the ability to balance rigorous treatment standards with the subjective experience of a patient’s physical and emotional needs.

Omnicell 52

Omnicell Patient Care Documentation Hospitals 52

Omnicell

SEPTEMBER 5, 2022

In fact, in a 2020 ISMP Sterile Compounding Pulse Check conducted with 634 pharmacy practitioners, only 25% of respondents report using technologies that include barcode verification, images, and gravimetric verification for 50% of compounded sterile products. . image capture, gravimetrics, flowmetrics and/or optical volume recognition.

Compounding 52

Compounding Sterile Compounds Documentation Compounding Pharmacies 52

Omnicell

JANUARY 10, 2023

Lisa Armburger Director, Client Success Executive, Omnicell 340B The pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. In light of the bold contract pharmacy actions of 2020, this is an area that is becoming more critical.

Omnicell 40

Omnicell Hospitals Documentation 40

Omnicell

JANUARY 10, 2023

The investigation, which included inquiries requesting large amounts of documents and communications from various stakeholders, is largely perceived as a drug industry-friendly fact-finding exercise. 2020: After being sued once again by 340B providers, HRSA established the Administrative Dispute Resolution program.

Hospitals 96

Hospitals Insurance Omnicell Documentation 96

Omnicell

JANUARY 10, 2023

In 2020, the agency stated on several occasions, including to 340B Report , that it did not have the legal authority to enforce the contract program and compel manufacturers to provide 340B discounts dispensed by contract pharmacies. The agency's position changed starting in late 2020.

Documentation 52

Documentation 52